Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma exchange plus convalescent plasma in hospitalized COVID-19 patients
IRCT20200416047099N2Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of albumin (human), fresh-frozen plasma and convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Size of lesion on lung, Body temperature and 7 more. Started Jun 2020; status: completed.
02
Drugs
albumin (human)fresh-frozen plasmaconvalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200416047099N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200416047099N2.